Cargando…

A new type of glycoconjugate vaccine containing Klebsiella fimbriae type 1 and 3 as carrier proteins

Detalles Bibliográficos
Autores principales:	Witkowska, D, Mieszala, M, Czamy, A, Kübler, J, Gamian, A, Przondo-Mordarska, A, Forest, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1997
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495484/ http://dx.doi.org/10.1186/cc40

Ejemplares similares

Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation
por: Schroll, Casper, et al.
Publicado: (2010)

The strongest resistance of Staphylococcus aureus to erythromycin is caused by decreasing uptake of the antibiotic into the cells
por: Piątkowska, Elżbieta, et al.
Publicado: (2012)

Carriers and Antigens: New Developments in Glycoconjugate Vaccines
por: van der Put, Robert M.F., et al.
Publicado: (2023)

Biofilm formation of Klebsiella pneumoniae on urethral catheters requires either type 1 or type 3 fimbriae
por: Stahlhut, Steen G, et al.
Publicado: (2012)

IscR Regulation of Type 3 Fimbriae Expression in Klebsiella pneumoniae CG43
por: Lin, Tien-Huang, et al.
Publicado: (2017)

Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases
por: Khatuntseva, E. A., et al.
Publicado: (2021)

Phosphorylated OmpR Is Required for Type 3 Fimbriae Expression in Klebsiella pneumoniae Under Hypertonic Conditions
por: Lin, Tien-Huang, et al.
Publicado: (2018)

Fimbriae reprogram host gene expression – Divergent effects of P and type 1 fimbriae
por: Ambite, Ines, et al.
Publicado: (2019)

KbvR mutant of Klebsiella pneumoniae affects the synthesis of type 1 fimbriae and provides protection to mice as a live attenuated vaccine
por: Zhang, Fusheng, et al.
Publicado: (2022)

CRP-Cyclic AMP Regulates the Expression of Type 3 Fimbriae via Cyclic di-GMP in Klebsiella pneumoniae
por: Lin, Ching-Ting, et al.
Publicado: (2016)

Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends
por: Micoli, Francesca, et al.
Publicado: (2018)

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
por: Palmieri, Elena, et al.
Publicado: (2022)

Klebsiella pneumoniae Type VI Secretion System Contributes to Bacterial Competition, Cell Invasion, Type-1 Fimbriae Expression, and In Vivo Colonization
por: Hsieh, Pei-Fang, et al.
Publicado: (2019)

The Amadori rearrangement as glycoconjugation method: Synthesis of non-natural C-glycosyl type glycoconjugates
por: Gallas, Katharina, et al.
Publicado: (2012)

Investigation of the Binding of Lectins with Polymer Glycoconjugates and the Glycoconjugates Containing Silver Nanoparticles by Means of Optical Spectroscopy and Light Scattering
por: Samoilova, N. A., et al.
Publicado: (2022)

Conserved FimK Truncation Coincides with Increased Expression of Type 3 Fimbriae and Cultured Bladder Epithelial Cell Association in Klebsiella quasipneumoniae
por: Venkitapathi, Sundharamani, et al.
Publicado: (2022)

Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines
por: Anish, Chakkumkal, et al.
Publicado: (2021)

Necrotizing enterocolitis is preceded by increased gut bacterial replication, Klebsiella, and fimbriae-encoding bacteria
por: Olm, Matthew R., et al.
Publicado: (2019)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022)

Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
por: Möginger, Uwe, et al.
Publicado: (2016)

B Cell Epitopes of Four Fimbriae Antigens of Klebsiella pneumoniae: A Comprehensive In Silico Study for Vaccine Development
por: Zargaran, Fatemeh Nemati, et al.
Publicado: (2020)

Intramolecular crankshaft-type rearrangement in a photoisomerised glycoconjugate
por: Hricovíni, Michal, et al.
Publicado: (2023)

EtcABC, a Putative EII Complex, Regulates Type 3 Fimbriae via CRP-cAMP Signaling in Klebsiella pneumoniae
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2019)

Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa
por: Hegerle, Nicolas, et al.
Publicado: (2018)

Glycoconjugate vaccines: classic and novel approaches
por: Adamo, Roberto
Publicado: (2021)

Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
por: Stefanetti, G., et al.
Publicado: (2020)

MrkH, a Novel c-di-GMP-Dependent Transcriptional Activator, Controls Klebsiella pneumoniae Biofilm Formation by Regulating Type 3 Fimbriae Expression
por: Wilksch, Jonathan J., et al.
Publicado: (2011)

Conjugation of Meningococcal Lipooligosaccharides Through Their Non-Reducing Terminus Results in Improved Induction a Protective Immune Response
por: Mieszała, Małgorzata, et al.
Publicado: (2019)

Adhesion of Escherichia Coli to Nanostructured Surfaces and the Role of Type 1 Fimbriae
por: Kallas, Pawel, et al.
Publicado: (2020)

Cinnamaldehyde Resist Salmonella Typhimurium Adhesion by Inhibiting Type I Fimbriae
por: Yin, Lizi, et al.
Publicado: (2022)

Retaining the structural integrity of disulfide bonds in diphtheria toxoid carrier protein is crucial for the effectiveness of glycoconjugate vaccine candidates
por: Carboni, Filippo, et al.
Publicado: (2022)

Chemical Synthesis of Rare, Deoxy-Amino Sugars Containing Bacterial Glycoconjugates as Potential Vaccine Candidates
por: Behera, Archanamayee, et al.
Publicado: (2018)

Stereoselective Synthesis of Selenium-Containing Glycoconjugates via the Mitsunobu Reaction
por: Serpico, Luigia, et al.
Publicado: (2021)

Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development
por: Colombo, Cinzia, et al.
Publicado: (2018)

Recent advances in the production of recombinant glycoconjugate vaccines
por: Kay, Emily, et al.
Publicado: (2019)

Expanding polysaccharide–protein coupling of glycoconjugate vaccines
por: Berti, Francesco
Publicado: (2022)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2022)

Recent advances on smart glycoconjugate vaccines in infections and cancer
por: Anderluh, Marko, et al.
Publicado: (2021)

Porphyromonas gingivalis fimbriae
por: Enersen, Morten, et al.
Publicado: (2013)

Uncoiling Mechanics of Escherichia coli Type I Fimbriae Are Optimized for Catch Bonds
por: Forero, Manu, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_pcdr4a32skp1dqr3mifpf2e5uo